Wells Fargo Remains a Hold on Vertex Pharmaceuticals (VRTX)
Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target ...
Evercore ISI Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...
IEEE14d
Quantum Feasibility Labeling for NP-Complete Vertex Coloring Problem
Currently, neither existing classical nor quantum algorithms can solve these problems in polynomial time. To address this difficulty, this paper proposes a quantum feasibility labeling (QFL) algorithm ...
TechCrunch20d
Google adds its voice model Chirp 3 to its Vertex AI platform
In the latest development, Google today announced that it would be adding Chirp 3 — its speech-to-text and HD text-to-speech models — to its Vertex AI development platform starting next week.
Yahoo Finance20d
Vertex Up 25% YTD: Should You Buy, Sell or Hold the Stock?
Vertex holds a dominant position in the cystic franchise (“CF”) market. Its CF sales continue to grow, driven by higher sales of Trikafta/Kaftrio in younger age groups. Vertex’s CF product ...
The Motley Fool26d
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...